Medicament for treating perimenopausal syndromes and preparation method thereof

Abstract

The invention relates to the field of medical technology, and more specifically provides a medicament for treating perimenopausal syndromes and a preparation method thereof. The medicament has the advantages of good curative effects, usage convenience, and extremely good mouthfeel. The medicament for treating perimenopausal syndromes is prepared by the following raw materials in parts by weight: 18-24 parts of cooked rehmannia roots, 16-20 parts of cornus fruits, 16-20 parts of dioscorea roots, 16-20 parts of poria, 16-20 parts of alisma tubers, 16-20 parts of moutan barks, 14-18 parts of gardenia fruits, 14-18 parts of bupleurum roots, 14-18 parts of Chinese angelica, 14-18 parts of white peony roots, 24-30 parts of spina date seeds, 14-18 parts of scutellaria roots, 10-14 parts of turtle shells, and 20-28 parts of oysters; and the medicament is prepared by using a certain preparation method.

Description

1. Technical field: [0001] The invention relates to the field of medical technology, in particular to a medicine for treating perimenopausal syndrome and a preparation method thereof. 2. Background technology: [0002] Perimenopausal syndrome, also known as menopausal syndrome (MPS), refers to a series of syndromes mainly caused by autonomic nervous system dysfunction and accompanied by neuropsychological symptoms caused by the fluctuation or decrease of sex hormones in women before and after menopause. Clinical manifestations: Emotional instability, decreased self-control, tension and anxiety, depression, headache, dizziness, occasional vomiting, skin itching or paresthesia, paroxysmal facial flushing, sweating, some women have memory loss, inattention, some Insomnia, tinnitus and other symptoms. [0003] For the treatment of perimenopausal syndrome, Western medicine mainly adopts hormone therapy, that is, estrogen replacement and supplementation therapy. By supplementing ...

AI Technical Summary

Problems solved by technology

[0007] At present, there is no Chinese patent medicine preparation related to Zishen Qinggan treatment of perimenopausal syndrome on the market, and there is no Chinese patent medicine preparation for the prevention of the disease. There are scattered papers reporting the clinical application of self-made Zishen Qinggan Granules, etc., but due to its use Occasionally, it needs to be taken with water. After taking it, the volume is large, and the taste is bitter and unacceptable. Especially oral decoction is likely to increase the anxiety and mental burden of menopausal women, and the medication compliance is poor, which affects the curative effect